Dr Contreras expressed further concerns in her letter to Dr Rotblat saying that inclusion of ALT testing information on commercial products may lead to these products considered superior against those not ALT tested, while there is no evidence for any difference.
Chronology Information
Date:
Chapter/issue
Hepatitis C Surrogate Screening
Key Person(s)
Dr Frances Rotblat
Dame Carmen Marcela Contreras